Berlin – As spring approaches, Germany is grappling with a surge in respiratory illnesses, leaving many wondering what’s circulating – the common cold, influenza, or COVID-19. Recent data indicates a significant rise in infections, placing a strain on healthcare systems and prompting public health officials to urge caution. Understanding the current situation, recognizing symptoms, and taking preventative measures are crucial as the nation navigates this period of heightened respiratory activity.
The current wave of illness isn’t a surprise, as respiratory infections typically peak during the colder months and into early spring. However, the interplay between different viruses – COVID-19, influenza, and the common cold – makes diagnosis and management more complex. The overlapping symptoms can make it difficult for individuals to determine the cause of their illness without testing, and this uncertainty impacts public health efforts to track and control the spread of each virus.
Current Infection Rates and Trends
According to recent reports, Germany is experiencing a high number of acute respiratory infections. Data from October 13, 2025, indicated approximately 7.5 million people were newly infected with a respiratory illness each week. Tagesschau.de reported that this represents a significant increase compared to the previous week, maintaining a high level of infection across the country. The situation is particularly noticeable in medical practices, with doctors reporting extended working hours to accommodate the influx of patients.
Oliver Abbushi, Chairman of the Association of Statutory Health Insurance Physicians in Munich, noted the significant increase in patient volume since mid-October during Oktoberfest. The large gatherings and often poorly ventilated spaces during the festival create an ideal environment for viruses to spread. While the exact breakdown of infections isn’t always clear, Abbushi indicated a substantial number of cases are attributable to the coronavirus, though influenza cases are too present.
The Techniker Krankenkasse has also observed a concerning trend: a decline in the number of people getting vaccinated against influenza. The willingness to obtain vaccinated is higher in eastern Germany compared to western Germany, highlighting regional disparities in preventative healthcare practices.
Symptoms: Distinguishing Between Illnesses
One of the biggest challenges in managing the current wave of respiratory infections is the similarity in symptoms between COVID-19, influenza, and the common cold. Common symptoms include sore throat, cough, and runny nose. However, You’ll see some key differences. Fever is more frequently associated with influenza and COVID-19 than with the common cold. Influenza symptoms also tend to appear more suddenly.
Differentiating between these illnesses requires testing, which is crucial for appropriate treatment and public health tracking. While many individuals experience mild symptoms, vulnerable populations – including the elderly, those with underlying health conditions, and the immunocompromised – are at higher risk of severe complications.
COVID-19’s Continued Presence
Despite widespread vaccination efforts, COVID-19 continues to circulate in Germany. The virus has mutated over time, leading to new variants that can evade immunity from previous infections or vaccinations. While the severity of illness has generally decreased with newer variants, COVID-19 remains a significant public health concern, particularly for those who are unvaccinated or have not received booster doses.
The Robert Koch Institute continues to monitor the spread of COVID-19 and provide guidance on preventative measures, such as vaccination, mask-wearing, and social distancing. The institute’s data is essential for informing public health policies and protecting vulnerable populations.
Influenza and RSV: Additional Challenges
Influenza, commonly known as the flu, is a highly contagious viral infection that can cause severe illness and complications. The influenza virus constantly evolves, requiring annual vaccination to ensure protection against the latest strains. The decline in influenza vaccination rates is a cause for concern, as it increases the risk of widespread outbreaks and severe illness.
Respiratory Syncytial Virus (RSV) is another common respiratory virus that can cause serious illness, particularly in young children and older adults. RSV typically causes mild, cold-like symptoms, but it can lead to bronchiolitis and pneumonia in vulnerable populations. There is now a preventative antibody available for infants to protect against RSV, offering a new layer of defense against this common virus.
Impact on the Healthcare System
The surge in respiratory infections is placing a significant strain on the German healthcare system. Hospitals are reporting increased admissions of patients with respiratory illnesses, leading to bed shortages and increased workload for healthcare workers. The situation is particularly challenging in regions with already limited healthcare resources.
The increased demand for healthcare services is also impacting access to routine medical care. Patients may experience longer wait times for appointments and procedures, and some non-essential services may be postponed. Healthcare officials are urging the public to practice preventative measures to reduce the spread of respiratory infections and alleviate the burden on the healthcare system.
Biontech’s Challenges
Recent developments at Biontech, the German company that developed one of the leading COVID-19 vaccines, have also drawn attention. The departure of the company’s founders has led to a decline in its stock price, raising questions about its future direction. RND.de reported on this situation, highlighting the potential impact on the company’s research and development efforts.
Preventative Measures and Recommendations
Public health officials are emphasizing the importance of preventative measures to reduce the spread of respiratory infections. These measures include:
- Vaccination: Getting vaccinated against COVID-19 and influenza is the most effective way to protect yourself and others from these viruses.
- Hygiene: Practicing good hygiene, such as frequent handwashing and covering coughs and sneezes, can help prevent the spread of germs.
- Mask-Wearing: Wearing a mask in crowded indoor settings can reduce the risk of transmission.
- Social Distancing: Maintaining physical distance from others can help limit exposure to respiratory viruses.
- Staying Home When Sick: If you are feeling unwell, stay home to avoid spreading the illness to others.
Individuals experiencing symptoms of a respiratory infection should consult with a healthcare professional for diagnosis and treatment. Early diagnosis and treatment can help prevent complications and reduce the spread of the virus.
The current situation underscores the importance of ongoing vigilance and proactive public health measures. As Germany navigates this period of heightened respiratory activity, a collective effort to protect ourselves and others is essential.
Looking ahead, continued monitoring of infection rates, vaccination coverage, and the emergence of new variants will be crucial for informing public health policies and protecting the health of the population. The next official update from the Robert Koch Institute is expected on March 20, 2026, providing further insights into the evolving situation. We encourage readers to share their experiences and thoughts in the comments below.
Worth a look